Sharma S - Search Results

1

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.

Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R, Cameron RB, Strieter R, Dubinett S, Sharma S. Srivastava MK, et al. Among authors: sharma s. Immunotargets Ther. 2012 Oct 1;2012(1):7-12. doi: 10.2147/ITT.S32617. Immunotargets Ther. 2012. PMID: 24791250 Free PMC article.

2

Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.

Andersson A, Srivastava MK, Harris-White M, Huang M, Zhu L, Elashoff D, Strieter RM, Dubinett SM, Sharma S. Andersson A, et al. Among authors: sharma s. Clin Cancer Res. 2011 Jun 1;17(11):3660-72. doi: 10.1158/1078-0432.CCR-10-3346. Clin Cancer Res. 2011. PMID: 21636553 Free PMC article.

3

Myeloid suppressor cells and immune modulation in lung cancer.

Srivastava MK, Andersson Å, Zhu L, Harris-White M, Lee JM, Dubinett S, Sharma S. Srivastava MK, et al. Among authors: sharma s. Immunotherapy. 2012 Mar;4(3):291-304. doi: 10.2217/imt.11.178. Immunotherapy. 2012. PMID: 22401635 Free PMC article. Review.

4

Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Srivastava MK, Zhu L, Harris-White M, Kar UK, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S. Srivastava MK, et al. Among authors: sharma s. PLoS One. 2012;7(7):e40677. doi: 10.1371/journal.pone.0040677. Epub 2012 Jul 16. PLoS One. 2012. PMID: 22815789 Free PMC article.

5

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer.

Srivastava MK, Dubinett S, Sharma S. Srivastava MK, et al. Among authors: sharma s. Oncoimmunology. 2012 Dec 1;1(9):1650-1651. doi: 10.4161/onci.21970. Oncoimmunology. 2012. PMID: 23264925 Free PMC article.

6

CCL21 Chemokine Therapy for Lung Cancer.

Sharma S, Zhu L, Srivastava MK, Harris-White M, Huang M, Lee JM, Rosen F, Lee G, Wang G, Kickhoefer V, Rome LH, Baratelli F, St John M, Reckamp K, Chul-Yang S, Hillinger S, Strieter R, Dubinett S. Sharma S, et al. Int Trends Immun. 2013 Jan;1(1):10-15. Int Trends Immun. 2013. PMID: 25264541 Free PMC article.

7

Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.

Sharma S, Batra RK, Yang SC, Hillinger S, Zhu L, Atianzar K, Strieter RM, Riedl K, Huang M, Dubinett SM. Sharma S, et al. Hum Gene Ther. 2003 Nov 1;14(16):1511-24. doi: 10.1089/104303403322495025. Hum Gene Ther. 2003. PMID: 14577913 Free PMC article.

8

EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.

Hillinger S, Yang SC, Zhu L, Huang M, Duckett R, Atianzar K, Batra RK, Strieter RM, Dubinett SM, Sharma S. Hillinger S, et al. Among authors: sharma s. J Immunol. 2003 Dec 15;171(12):6457-65. doi: 10.4049/jimmunol.171.12.6457. J Immunol. 2003. PMID: 14662845

9

Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.

Yang SC, Hillinger S, Riedl K, Zhang L, Zhu L, Huang M, Atianzar K, Kuo BY, Gardner B, Batra RK, Strieter RM, Dubinett SM, Sharma S. Yang SC, et al. Among authors: sharma s. Clin Cancer Res. 2004 Apr 15;10(8):2891-901. doi: 10.1158/1078-0432.ccr-03-0380. Clin Cancer Res. 2004. PMID: 15102698

10

CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.

Strieter RM, Belperio JA, Burdick MD, Sharma S, Dubinett SM, Keane MP. Strieter RM, et al. Among authors: sharma s. Ann N Y Acad Sci. 2004 Dec;1028:351-60. doi: 10.1196/annals.1322.041. Ann N Y Acad Sci. 2004. PMID: 15650260 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,126 results

Search Page

Filters